| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.2 |